1-5 of 5
Jeffrey C. Kurz, PhD
Close
Sort by
Journal Articles

Investigation Into the Mechanism of Action and Binding Site of BAX 499, An Aptamer Against Tissue Factor Pathway Inhibitor

Emily K. Waters, PhD, Ryan M. Genga, Heather A. Thomson, Robert G. Schaub, PhD, Jeffrey C. Kurz, PhD, Kathleen E. McGinness, PhD
Journal: Blood
Blood (2011) 118 (21): 1214.
https://doi.org/10.1182/blood.V118.21.1214.1214
Published: 2011
Journal Articles

TFPI Antagonist Aptamer ARC19499 Is a Procoagulant In Vitro and In Vivo.

Kathleen E. McGinness, PhD, Emily K. Waters, PhD, Ryan M. Genga, Karen A. Olson, PhD, Jennifer A. Nelson, PhD, Jeffrey C. Kurz, PhD, Robert G. Schaub, PhD
Journal: Blood
Blood (2010) 116 (21): 1134.
https://doi.org/10.1182/blood.V116.21.1134.1134
Published: 2010
Journal Articles

Discovery and Characterization of An Anti-APC Aptamer for Use In Hemophilia

Patricia G.M. Wagner, Michael C. Schwartz, Kathleen E. McGinness, Ryan M. Genga, Jeffrey C. Kurz, PhD, Emily K. Waters, PhD, Robert Schaub, PhD
Journal: Blood
Blood (2010) 116 (21): 2222.
https://doi.org/10.1182/blood.V116.21.2222.2222
Published: 2010
Journal Articles

Evaluation of a Novel Anti-P-Selectin Aptamer ARC5690 On Venous Inflammation Following Acute Venous Thrombosis.

Jose Antonio Diaz, MD, Patrick A Lester, DVM, Jeffrey C Kurz, PhD, Shirley K Wrobleski, BS, LVT, Angela E Hawley, BS, Robert E Sigler, DVM, PhD, Thomas W Wakefield, MD, Robert G Schaub, PhD, Daniel Myers, DVM, MPH, DACLAM
Journal: Blood
Blood (2009) 114 (22): 3599.
https://doi.org/10.1182/blood.V114.22.3599.3599
Published: 2009
Journal Articles

An Aptamer Antagonist of Tissue Factor Pathway Inhibitor Improves Coagulation in Hemophilia A and FVIII Antibody-Treated Plasma.

Emily K. Waters, PhD, Jeffrey C. Kurz, PhD, Ryan Genga, Jennifer A Nelson, PhD, Kathleen E. McGinness, PhD, Robert G. Schaub, PhD
Journal: Blood
Blood (2009) 114 (22): 544.
https://doi.org/10.1182/blood.V114.22.544.544
Published: 2009